Clare Market Investments LLC Invests $860,000 in UnitedHealth Group Incorporated $UNH

Clare Market Investments LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the first quarter, HoldingsChannel reports. The fund bought 3,180 shares of the healthcare conglomerate’s stock, valued at approximately $860,000.

Several other hedge funds have also added to or reduced their stakes in the business. Kiley Juergens Wealth Management LLC acquired a new position in shares of UnitedHealth Group during the first quarter worth $253,000. Walser Wealth Management Company A Ltd Liability Co raised its position in shares of UnitedHealth Group by 81.9% during the first quarter. Walser Wealth Management Company A Ltd Liability Co now owns 4,186 shares of the healthcare conglomerate’s stock worth $1,133,000 after acquiring an additional 1,885 shares during the last quarter. Schear Investment Advisers LLC increased its position in UnitedHealth Group by 1.7% during the 1st quarter. Schear Investment Advisers LLC now owns 5,361 shares of the healthcare conglomerate’s stock valued at $1,451,000 after purchasing an additional 92 shares during the period. PUREfi Wealth LLC lifted its position in shares of UnitedHealth Group by 76.4% in the 1st quarter. PUREfi Wealth LLC now owns 3,269 shares of the healthcare conglomerate’s stock worth $884,000 after purchasing an additional 1,416 shares during the period. Finally, Kathmere Capital Management LLC increased its position in shares of UnitedHealth Group by 21.6% during the first quarter. Kathmere Capital Management LLC now owns 6,942 shares of the healthcare conglomerate’s stock worth $1,878,000 after buying an additional 1,233 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth is shifting its strategy toward profitability over rapid growth, with improving margins, stronger earnings, and Optum expansion seen as supporting a longer-term turnaround. UnitedHealth Bets on Profitability Over Growth: Will It Pay Off?
• Positive Sentiment: HSBC raised its price target on UNH to $380 and maintained a “hold” rating, reflecting continued analyst attention and a more favorable valuation view than before. HSBC raises UnitedHealth price target
• Positive Sentiment: Multiple recent analyst targets remain well above prior levels, including targets in the mid-$400s, which supports the view that Wall Street still sees recovery potential in the stock.
• Positive Sentiment: UnitedHealth became the first major commercial insurer to cover Guardant Health’s Shield blood test for colorectal cancer screening in eligible adults 45 and older, a move that could strengthen its role in emerging preventative care and improve access to innovative screening tools. UnitedHealth Group Opens Shield Blood Test Coverage
• Neutral Sentiment: Market commentary continues to frame UNH as a long-term momentum name and a defensive healthcare holding, suggesting investors still view it as a quality large-cap stock with stable fundamentals.
• Negative Sentiment: The stock declined in the latest trading session even as the broader market improved, indicating some near-term profit-taking or investor caution despite the favorable long-term setup. UnitedHealth Group Stock Declines While Market Improves

UnitedHealth Group Stock Up 1.6%

Shares of NYSE UNH opened at $424.51 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $430.20. The stock has a market capitalization of $385.51 billion, a P/E ratio of 32.08, a P/E/G ratio of 1.71 and a beta of 0.62. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80. The company has a 50-day moving average price of $392.87 and a 200-day moving average price of $335.60.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The business had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same quarter in the previous year, the business earned $7.20 EPS. The company’s quarterly revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 18.32 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were issued a dividend of $2.32 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a yield of 2.2%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s payout ratio is presently 70.09%.

Analyst Ratings Changes

UNH has been the subject of a number of recent analyst reports. Truist Financial increased their price target on UnitedHealth Group from $395.00 to $440.00 and gave the stock a “buy” rating in a report on Monday, June 1st. Morgan Stanley boosted their price target on UnitedHealth Group from $453.00 to $468.00 and gave the company an “overweight” rating in a research note on Tuesday, June 30th. UBS Group lifted their price objective on shares of UnitedHealth Group from $410.00 to $460.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. TD Cowen restated a “buy” rating on shares of UnitedHealth Group in a report on Monday, June 22nd. Finally, HC Wainwright set a $492.00 target price on UnitedHealth Group in a research note on Wednesday, May 27th. One research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $414.75.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the sale, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. This represents a 4.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.28% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.